Reassessment of 4-Cycle Etoposide and Cisplatin as the Standard of Care for Good-Risk Metastatic Germ Cell Tumors. [electronic resource]
Producer: 20191022Description: 1661-1662 p. digitalISSN:- 2374-2445
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bleomycin -- administration & dosage
- Choice Behavior
- Cisplatin -- administration & dosage
- Dose-Response Relationship, Drug
- Etoposide -- administration & dosage
- Guideline Adherence -- standards
- Humans
- Male
- Neoplasm Metastasis
- Neoplasms, Germ Cell and Embryonal -- drug therapy
- Quality of Life
- Standard of Care
- Survival Rate
- Testicular Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.